Illinois Municipal Retirement Fund bought a new position in shares of Astrana Health, Inc. (NASDAQ:ASTH – Free Report) during the first quarter, HoldingsChannel reports. The firm bought 18,492 shares of the company’s stock, valued at approximately $453,000.
Other large investors also recently bought and sold shares of the company. Signaturefd LLC grew its position in shares of Astrana Health by 57.9% in the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock worth $26,000 after acquiring an additional 388 shares in the last quarter. GAMMA Investing LLC raised its position in shares of Astrana Health by 144.7% during the 4th quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock valued at $37,000 after acquiring an additional 871 shares in the last quarter. Strs Ohio acquired a new stake in shares of Astrana Health during the 4th quarter valued at approximately $40,000. Tower Research Capital LLC TRC lifted its stake in Astrana Health by 323.3% during the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after purchasing an additional 3,517 shares during the last quarter. Finally, State of Wyoming bought a new position in Astrana Health during the second quarter worth $132,000. Institutional investors own 52.77% of the company’s stock.
Astrana Health Price Performance
Shares of ASTH opened at $40.31 on Friday. The company has a market cap of $2.25 billion, a P/E ratio of 66.08 and a beta of 0.89. The stock has a fifty day moving average price of $41.78 and a 200 day moving average price of $31.87. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.35 and a quick ratio of 1.35. Astrana Health, Inc. has a 12 month low of $18.08 and a 12 month high of $51.60.
Wall Street Analyst Weigh In
A number of equities analysts have commented on the stock. Needham & Company LLC lifted their price objective on shares of Astrana Health from $30.00 to $41.00 and gave the stock a “buy” rating in a report on Friday, May 8th. Barclays raised shares of Astrana Health from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $37.00 to $50.00 in a report on Tuesday, May 26th. BTIG Research boosted their price objective on shares of Astrana Health from $50.00 to $65.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Robert W. Baird set a $45.00 price objective on shares of Astrana Health in a research note on Friday, May 8th. Finally, Truist Financial raised their target price on shares of Astrana Health from $38.00 to $47.00 and gave the stock a “buy” rating in a report on Thursday, May 14th. Seven investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to data from MarketBeat.com, Astrana Health has a consensus rating of “Moderate Buy” and an average target price of $47.86.
Get Our Latest Stock Report on Astrana Health
About Astrana Health
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.
See Also
- Five stocks we like better than Astrana Health
- AMD and Cerbras Create A New Blueprint For Hardware
- Intel Earnings Reveal Whether the Chip Selloff Created a Buy
- CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
- Plugging In: How Kinder Morgan Powers Up Profits
Want to see what other hedge funds are holding ASTH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Astrana Health, Inc. (NASDAQ:ASTH – Free Report).
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.
